Q2 2025 Auna SA Earnings Call Transcript
Key Points
- Auna SA (AUNA) reported a 5% growth in consolidated FX neutral EBITDA, indicating a positive trajectory across its operations.
- The company achieved a record low oncology Medical Loss Ratio (MLR) in Peru, reflecting improved efficiencies in pharmaceutical costs.
- Mexico's revenue grew 5% year over year, driven by higher average tickets for surgeries and emergency treatments.
- Colombia's EBITDA increased by 9% with an improved margin, showcasing effective risk management and cash flow improvements.
- Auna SA (AUNA) successfully refinanced over $62 million of short-term debt, enhancing its maturity profile and debt structure.
- Total capacity utilization decreased by 2.5 percentage points to 64%, primarily due to intentional growth slowing in Colombia.
- Mexico faced lower surgery volumes and emergency visits, impacting hospitalizations and ICU admissions.
- The depreciation of the Mexican and Colombian pesos against the Peruvian Sol negatively affected reported EBITDA.
- The company's leverage ratio remained unchanged, with a medium-term target of 3 times net debt to EBITDA yet to be achieved.
- Free cash flow was negatively impacted by payments to OncologĂa doctors and collections issues in Colombia.
Good morning and welcome to Auna's second quarter 2025 earnings conference call. My name is Ellie, and I will be your operator for today's call. At this time, all participants are in listen-only mode. Please note that this call is being recorded. There will be an opportunity to ask a question at the end of today's presentation.
Now, I would like to turn the call over to Ana Maria Mora, Head of Investor Relations. Ma'am, please go ahead.
Thank you, operator. Hello, everyone, and welcome to AUNA's conference call to review our second quarter results. Please note that there is a webcast presentation to accompany the discussion during this call. If you need a copy of the presentation, please go to our investor relations website or contact Auna's investor relations team.
Please note that when we discuss variances, we will be doing so on a year over year basis and in FX neutral or local currency terms with regards to Mexico and Colombia, unless we know otherwise.
Let's move to life too.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
